Labcorp Holdings (LH) EBT (2009 - 2026)

Labcorp Holdings has disclosed EBT across 18 years of filings, most recently posting $319.7 million for Q1 2026.

• EBT for Q1 2026 came in at $319.7 million, up 16.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 22.91% YoY), and the FY2025 annual result was $1.1 billion, up 15.42% from the prior year.
• EBT came in at $319.7 million for Q1 2026 at Labcorp Holdings, up from $190.6 million in the prior quarter.
• In the past five years, EBT ranged from a high of $640.1 million in Q1 2022 to a low of -$147.1 million in Q4 2023.
• The 5-year median for EBT is $272.3 million (2023), against an average of $251.9 million.
• Across the five-year window, EBT slumped 1542.16% in 2023 and soared 224.95% in 2024, its largest moves.
• Labcorp Holdings' EBT stood at $10.2 million in 2022, then plunged by 1542.16% to -$147.1 million in 2023, then jumped by 224.95% to $183.8 million in 2024, then rose by 3.7% to $190.6 million in 2025, then surged by 67.73% to $319.7 million in 2026.
• The last three EBT figures came in at $319.7 million (Q1 2026), $190.6 million (Q4 2025), and $337.0 million (Q3 2025), per Business Quant data.